Gene · 5154
Papers4,148
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,148
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatiotemporal Characterization of Human Early Intervertebral Disc Formation at Single-Cell Resolution. | Adv Sci (Weinh) | 2023 | 36965031 | PubTator, text mining | PubMed |
| Identification of the regulatory mechanism of ACE2 in COVID-19-induced kidney damage with systems genetics approach. | J Mol Med (Berl) | 2023 | 36951969 | PubTator, text mining | PubMed |
| Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients. | PLoS One | 2023 | 36940196 | PubTator, text mining | PubMed |
| Three-dimensional co-culture platform of human induced pluripotent stem cell-derived oligodendrocyte lineage cells and neurons for studying myelination. | STAR Protoc | 2023 | 36933222 | PubTator, text mining | PubMed |
| EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway. | J Transl Med | 2023 | 36932397 | PubTator, text mining | PubMed |
| Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice. | Nat Commun | 2023 | 36918564 | PubTator, text mining | PubMed |
| Smad4-mediated angiogenesis facilitates the beiging of white adipose tissue in mice. | iScience | 2023 | 36915676 | PubTator, text mining | PubMed |
| Age-associated microenvironmental changes highlight the role of PDGF-C in ER+ breast cancer metastatic relapse. | Nat Cancer | 2023 | 36914817 | PubTator, text mining | PubMed |
| New insights into fibrotic signaling in renal cell carcinoma. | Front Cell Dev Biol | 2023 | 36910160 | PubTator, text mining | PubMed |
| Identification of angiogenesis-related subtypes, the development of prognostic models, and the landscape of tumor microenvironment infiltration in colorectal cancer. | Front Pharmacol | 2023 | 36909170 | PubTator, text mining | PubMed |
| Functionalizing Collagen Membranes with MSC-Conditioned Media Promotes Guided Bone Regeneration in Rat Calvarial Defects. | Cells | 2023 | 36899904 | PubTator, text mining | PubMed |
| Uses of Vascular Endothelial Growth Factor C as a Lung Adenocarcinoma Prognostic Biomarker. | World J Oncol | 2023 | 36896001 | PubTator, text mining | PubMed |
| Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis. | Front Immunol | 2023 | 36895571 | PubTator, text mining | PubMed |
| Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice. | EMBO Rep | 2023 | 36880581 | PubTator, text mining | PubMed |
| Structural insights and shedding light on preferential interactions of dietary flavonoids with G-quadruplex DNA structures: A new horizon. | Heliyon | 2023 | 36879969 | PubTator, text mining | PubMed |
| Identification of phenotypically, functionally, and anatomically distinct stromal niche populations in human bone marrow based on single-cell RNA sequencing. | Elife | 2023 | 36876630 | PubTator, text mining | PubMed |
| Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer. | Clin Cancer Res | 2023 | 36862086 | PubTator, text mining | PubMed |
| Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6. | J Immunother Cancer | 2023 | 36849201 | PubTator, text mining | PubMed |
| Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of Hoxa cluster genes and promotion of neuronal lineage. | Neurooncol Adv | 2023 | 36845293 | PubTator, text mining | PubMed |
| Biodegradable biliary stents coated with mesenchymal stromal cells in a porcine choledochojejunostomy model. | Cytotherapy | 2023 | 36842850 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5154/papers?page=21